rytelo - imetelstat sodium injection, powder, lyophilized, for solution
(Imetelstat Sodium)Geron Corporation
Usage: RYTELO is indicated for adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) experiencing transfusion-dependent anemia, requiring 4+ red blood cell units in 8 weeks, who have not responded to, lost response to, or are ineligible for erythropoiesis-stimulating agents (ESA).